Sorrento Therapeutics, Inc. announced that Mr. George Uy, executive vice president and chief commercial officer, will be leaving the company at the end of July 2015 to join a start-up company as its chief executive officer.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0145 USD | +31.82% | +61.11% | -88.26% |
Apr. 10 | Sorrento Therapeutics, Inc. Emerged from Bankruptcy | CI |
Mar. 15 | Scilex Settles Claims in Case Against Virpax for $6 Million, 6% Royalties From Three Drugs | MT |
1st Jan change | Capi. | |
---|---|---|
-88.26% | 7.88M | |
+8.92% | 114B | |
+10.48% | 105B | |
-2.91% | 21.73B | |
-6.45% | 23.83B | |
-10.70% | 18.1B | |
-42.36% | 16.34B | |
-14.45% | 16.13B | |
+3.76% | 13.75B | |
+28.94% | 11.76B |
- Stock Market
- Equities
- SRNE Stock
- News Sorrento Therapeutics, Inc.
- George Uy Leaves Sorrento Therapeutics, Inc. as Executive Vice President and Chief Commercial Officer